Skip to main content
. 2023 Aug 31;14:1225513. doi: 10.3389/fmicb.2023.1225513

Figure 3.

Figure 3

MVs in immunomodulation. (A) CD80, CD86, HLA-DR, ICAM1, CCLD2, CCL3, CCL5, CXCL8, IL-1β, IL-6, IL-10, IL-12p40, IL-12p70 and TNF expression were increased, and CD14 expression and lipopolysaccharide-mediated responses were decreased. (B) CCL2, IFNγ, IL-12p40, IL-12p70, IL-16, and TNF levels were elevated, while phagocytic and chemotactic activities were reduced. (C) CCL3, CCL4, CXCL8, IL-1β, NETs and TNF were elevated, phagocytic and chemotactic activities were decreased. BioRender.com was used to create this.